Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38341
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorBITO, Virginie
dc.contributor.authorJager, Manon Marie
dc.date.accessioned2022-09-26T08:19:41Z-
dc.date.available2022-09-26T08:19:41Z-
dc.date.issued2022
dc.identifier.urihttp://hdl.handle.net/1942/38341-
dc.format.mimetypeApplication/pdf
dc.languageen
dc.publishertUL
dc.titleUsing pyridoxamine to limit cardiovascular toxicity during doxorubicin chemotherapy
dc.typeTheses and Dissertations
local.bibliographicCitation.jcatT2
dc.description.notesMaster of Biomedical Sciences-Molecular Mechanisms in Health and Disease
local.type.specifiedMaster thesis
item.fullcitationJager, Manon Marie (2022) Using pyridoxamine to limit cardiovascular toxicity during doxorubicin chemotherapy.-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
item.contributorJager, Manon Marie-
Appears in Collections:Master theses
Files in This Item:
File Description SizeFormat 
51293e0d-82f6-468c-9860-1e22f12597f7.pdf1.62 MBAdobe PDFView/Open
Show simple item record

Page view(s)

64
checked on Sep 10, 2023

Download(s)

84
checked on Sep 10, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.